Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women
Authors:
- 1 November 1992
- journal article
- Published by Elsevier in Metabolism
- Vol. 41 (11) , 1193-1198
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The Risk of Breast Cancer after Estrogen and Estrogen–Progestin ReplacementNew England Journal of Medicine, 1989
- Oral-Contraceptive Use and the Risk of Breast CancerNew England Journal of Medicine, 1986
- Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham populationAmerican Heart Journal, 1986
- A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart DiseaseNew England Journal of Medicine, 1985
- Postmenopausal Estrogen Use, Cigarette Smoking, and Cardiovascular Morbidity in Women over 50New England Journal of Medicine, 1985
- Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery DiseaseNew England Journal of Medicine, 1983
- Replacement Estrogens and Endometrial CancerNew England Journal of Medicine, 1979
- Endometrial Cancer and Estrogen UseNew England Journal of Medicine, 1979
- Estrogen use, hypertension and stroke in postmenopausal womenJournal of Chronic Diseases, 1978
- ANTITHROMBIN III AND THE ŒSTROGEN CONTENT OF COMBINED ŒSTRO-PROGESTAGEN CONTRACEPTIVESThe Lancet, 1972